SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-039770
Filing Date
2019-11-04
Accepted
2019-11-04 16:01:42
Documents
66
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q spro-10q_20190930.htm 10-Q 3366152
2 EX-31.1 spro-ex311_9.htm EX-31.1 22174
3 EX-31.2 spro-ex312_10.htm EX-31.2 22407
4 EX-32.1 spro-ex321_8.htm EX-32.1 9836
5 EX-32.2 spro-ex322_6.htm EX-32.2 9853
  Complete submission text file 0001564590-19-039770.txt   9877720

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT spro-20190930.xml EX-101.INS 2065203
7 XBRL TAXONOMY EXTENSION SCHEMA spro-20190930.xsd EX-101.SCH 69570
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE spro-20190930_cal.xml EX-101.CAL 56735
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE spro-20190930_def.xml EX-101.DEF 212044
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE spro-20190930_lab.xml EX-101.LAB 488689
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE spro-20190930_pre.xml EX-101.PRE 367571
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Filer) CIK: 0001701108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38266 | Film No.: 191189711
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences